Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Smoking

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 41 articles:
HTML format



Single Articles


    February 2021
  1. FRANCEY N
    30th anniversary of Australian legal ruling on second-hand smoke.
    Lancet. 2021;397:466-467.
    PubMed    


    November 2020
  2. DAUBE M, Swanson M
    Conflicts of interest should be declared.
    Lancet. 2020;396:1561-1562.
    PubMed    


    August 2020
  3. POSCHENRIEDER F, Rotter M, Gschwendtner A, Hamer OW, et al
    E-cigarette-induced lung disease: from acute to chronic.
    Lancet. 2020;396:564.
    PubMed    


    June 2020
  4. ZAROCOSTAS J
    Plain packaging ruling hailed as a victory for tobacco control.
    Lancet. 2020;395:1895.
    PubMed    


    February 2020
  5. SHAHAB L, Britton J, Brown J, Hajek P, et al
    The need for an evidence-based and rational debate on e-cigarettes.
    Lancet. 2020;395:688.
    PubMed    


  6. XUE Y
    Smoking cessation programmes in China.
    Lancet. 2020;395:e28.
    PubMed    


    December 2019
  7. ALEXANDER LEC, Perez MF
    Identifying, tracking, and treating lung injury associated with e-cigarettes or vaping.
    Lancet. 2019;394:2041-2043.
    PubMed    


  8. BLAGEV DP, Harris D, Dunn AC, Guidry DW, et al
    Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study.
    Lancet. 2019;394:2073-2083.
    PubMed     Abstract available


    November 2019
  9. JAFFE S
    Will Trump snuff out e-cigarettes?
    Lancet. 2019;394:1977-1978.
    PubMed    


  10. NEWTON JN
    Time for The Lancet to realign with the evidence on e-cigarettes?
    Lancet. 2019;394:1804-1805.
    PubMed    


  11. SALZMAN M
    Philip Morris International: time for a new conversation.
    Lancet. 2019;394:1711-1712.
    PubMed    


    October 2019
  12. THE LANCET
    E-cigarettes: time to realign our approach?
    Lancet. 2019;394:1297.
    PubMed    


    September 2019
  13. LI X, Galea G
    Healthy China 2030: an opportunity for tobacco control.
    Lancet. 2019;394:1123-1125.
    PubMed    


  14. ZHOU M, Wang H, Zeng X, Yin P, et al
    Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2019;394:1145-1158.
    PubMed     Abstract available


  15. HOPKINSON NS, Arnott D, Voulvoulis N
    Environmental consequences of tobacco production and consumption.
    Lancet. 2019;394:1007-1008.
    PubMed    


    August 2019
  16. BEAGLEHOLE R, Bates C, Youdan B, Bonita R, et al
    Nicotine without smoke: fighting the tobacco epidemic with harm reduction.
    Lancet. 2019;394:718-720.
    PubMed    


  17. THE LANCET
    Philip Morris International: money over morality?
    Lancet. 2019;394:709.
    PubMed    


  18. GHEBREYESUS TA
    Progress in beating the tobacco epidemic.
    Lancet. 2019;394:548-549.
    PubMed    


  19. TAN ASL, Soneji S, Moran MB, Choi K, et al
    JUUL Labs' sponsorship and the scientific integrity of vaping research.
    Lancet. 2019;394:366-368.
    PubMed    


    June 2019
  20. LEGG T, Peeters S, Chamberlain P, Gilmore AB, et al
    The Philip Morris-funded Foundation for a Smoke-Free World: tax return sheds light on funding activities.
    Lancet. 2019;393:2487-2488.
    PubMed    


  21. HUANG K, Yang T, Xu J, Yang L, et al
    Prevalence, risk factors, and management of asthma in China: a national cross-sectional study.
    Lancet. 2019 Jun 20. pii: S0140-6736(19)31147.
    PubMed     Abstract available


    May 2019
  22. DRANSFIELD M, Stolz D, Kleinert S
    Towards eradication of chronic obstructive pulmonary disease: a Lancet Commission.
    Lancet. 2019;393:1786-1788.
    PubMed    


    March 2019
  23. LAMB N
    E-cigarettes.
    Lancet. 2019;393:876.
    PubMed    


    September 2018

  24. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.
    Lancet. 2018;392:1072-1088.
    PubMed     Abstract available


    August 2018
  25. NEWTON JN, Dockrell M, Marczylo T
    Electronic cigarettes: adolescent health and wellbeing - Authors' reply.
    Lancet. 2018;392:474.
    PubMed    


  26. PETERS MJ
    Electronic cigarettes: adolescent health and wellbeing.
    Lancet. 2018;392:473-474.
    PubMed    


  27. BANDARA AN, Mehrnoush V
    Electronic cigarettes: adolescent health and wellbeing.
    Lancet. 2018;392:473.
    PubMed    


    July 2018
  28. BRITTON J
    Denicotinised cigarettes.
    Lancet. 2018;392:104-105.
    PubMed    


    April 2018
  29. WANG C, Xu J, Yang L, Xu Y, et al
    Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
    Lancet. 2018;391:1706-1717.
    PubMed     Abstract available


  30. THE LANCET
    UK COPD treatment: failing to progress.
    Lancet. 2018;391:1550.
    PubMed    


    March 2018
  31. THOMPSON AJ, Baranzini SE, Geurts J, Hemmer B, et al
    Multiple sclerosis.
    Lancet. 2018 Mar 22. pii: S0140-6736(18)30481.
    PubMed     Abstract available


    February 2018
  32. NEWTON JN, Dockrell M, Marczylo T
    Making sense of the latest evidence on electronic cigarettes.
    Lancet. 2018;391:639-642.
    PubMed    


    November 2017
  33. GARTNER C, Miller A, Bonevski B
    Extending survival for people with hepatitis C using tobacco dependence treatment.
    Lancet. 2017;390:2033.
    PubMed    


    September 2017
  34. BARNETT R
    Lung cancer.
    Lancet. 2017;390:928.
    PubMed    


    August 2017
  35. RIDKER PM, MacFadyen JG, Thuren T, Everett BM, et al
    Effect of interleukin-1beta inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial.
    Lancet. 2017 Aug 25. pii: S0140-6736(17)32247.
    PubMed     Abstract available


    July 2017
  36. THE LANCET
    Where next for UK tobacco control?
    Lancet. 2017;390:96.
    PubMed    


    January 2017
  37. STRINGHINI S, Carmeli C, Jokela M, Avendano M, et al
    Socioeconomic status and the 25 x 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1.7 million men and women.
    Lancet. 2017 Jan 31. pii: S0140-6736(16)32380.
    PubMed     Abstract available


  38. THE LANCET
    Tobacco elimination: an economic and public health imperative.
    Lancet. 2017;389:225.
    PubMed    


    October 2016
  39. GUAN WJ, Zheng XY, Chung KF, Zhong NS, et al
    Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action.
    Lancet. 2016;388:1939-1951.
    PubMed     Abstract available



  40. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.
    Lancet. 2016;388:1659-1724.
    PubMed     Abstract available


    July 2016
  41. O'DONNELL MJ, Chin SL, Rangarajan S, Xavier D, et al
    Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study.
    Lancet. 2016 Jul 15. pii: S0140-6736(16)30506.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Smoking is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: